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1. Introduction
The Age of Enlightenment is the period in time when the method of reasoning known as the
Scientific Method was developed. This revolution in science began with the description of the
sun as the center of our solar system rather than the earth. Natural phenomena previously
explained by spiritualists were now described by science. Given our still evolving under‐
standing of influenza, it is perhaps no coincidence that we describe the combined effects of the
influenza virus gene segments with the word ‘constellation’, which has astrological roots
describing the position of the stars. Interestingly, the name influenza also has astrological roots:
it was borrowed from the Italian word influenza in the mid-17th century which, in turn, was
derived from the Medieval Latin word influentia, a 14th century term that refers to the influence
of the stars. The scientific rational to describe the influence of the influenza gene constellation
on virus phenotype is currently being resolved. Here we try to shine some light on the subject
by providing the reader with background information, recent experimental results and
provide a framework for questions that remain unanswered.
Influenza is a common infectious respiratory disease caused by influenza viruses. The host
range of these viruses can include birds, humans and other mammals. Influenza viruses cause
seasonal epidemics and are almost globally ubiquitous. They cause significant morbidity and
mortality each year yet some infected persons remain asymptomatic. Influenza is typically
transmitted by aerosols produced by coughing or sneezing. Although virus particles on
contaminated surfaces can be easily inactivated, the virus is still able to spread easily and
rapidly. Vaccination is the recommended approach to prevent disease because of the possible
emergence of drug resistance.
Vaccines are produced each year to counter the currently circulating seasonal strains. The
influenza vaccine seed viruses used to produce the immunogenic proteins are reassortant
viruses. That is, they contain a mix of gene segments from different viruses. The genomes of
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the influenza A and B viruses are made up of eight negative-strand RNA segments. The
haemagglutinin (HA) and neuraminidase (NA) proteins found on the surface of the virus are
found on two different segments. Usually these two segments from a seasonal virus are
combined with another six gene segments from a high yield strain to make a vaccine seed
virus. HA is the major immunogenic protein recognized by the host immune system. Because
of influenza’s high rate of mutation, and the capacity of the genome to tolerate many mutations,
there is a need to update the influenza vaccine seed virus strains each year. The influenza virus
is able to avoid control by the host immune system via two major types of mutation. Antigenic
drift is the process of gradual genetic mutation, especially in the HA gene, that results in newer
viruses not being well recognized by antibodies that recognized the progenitor virus. Anti‐
genic shift is the replacement of one or more segments from one influenza virus with those of
another. This unpredictable event can lead to a change in host range, transmission or patho‐
genicity. Likewise, genetic reassortment, the mixing of genomic segments from different
strains, can generate undesirable characteristics in the influenza vaccine seed viruses. Here we
explore possible reasons for this and describe approaches that might be beneficial to the
development of influenza vaccine seed viruses.
2. The segmented influenza genome
The Orthomyxoviridae family is comprised of negative-sense, segmented RNA viruses. There
are three influenza genera, influenza A, B and C viruses, that belong to the family. Eight
negative-sense RNA segments make up the viral genome for the A and B viruses, one more
than the influenza C virus genome which has seven segments (Figure 1). The terminal ends of
each gene segment are conserved and this allows control over several aspects of the influenza
lifecycle. The terminal sequences are partially complementary and can form structures that
serve as regulatory signals for transcription and replication (Figure 1). The structures are
dynamic and it is thought that switching between the structures allows different steps of
replication to occur [1].
Each negative-sense viral RNA is encapsidated with nucleoprotein to form a ribonucleoprotein
(RNP). Attached to the 5’ end of each segment is the influenza polymerase complex [2]. This
arrangement allows a message RNA (mRNA) from each segment to be transcribed independ‐
ently of other segments in the nucleus. Most of the segments encode a single protein but some
of the RNA segments are spliced or have alternative translation mechanisms so that usually
more than 10 proteins are made during an infection [3;4]. The mRNAs transcribed from all the
segments are exported from the nucleus to the cytoplasm where they are translated into the
viral proteins. The nucleoprotein and polymerase proteins each contain nuclear localization
sequences and are imported into the nucleus where they participate in the production of new
viral RNA. Some of the remaining proteins are processed in the secretory pathway and
transported to the cell surface for incorporation into the virions while others remain in the
cytoplasm or nucleus and modulate the host cell immune response.
The negative-sense segmented genome bestows some advantages and disadvantages to the
virus. Having the genome divided up into segments creates some challenges such as ensuring
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that one of each segment is packaged into one virion. However, it also helps alleviate a problem
faced by many RNA viruses, the high error rate inherent in RNA synthesis. The error rate for
the influenza viruses has be calculated to be 2.0 x 10-6 and 0.6 x 10-6 mutations per site per
infectious cycle for influenza A and B respectively [5]. Rates ranging from 3.72 to 6.77 x 10-4
substitutions per site per year have been calculated for the influenza C segments [6]. Influen‐
za viruses can exist as a quasispecies, that is, a group of diverse viruses that collectively
contribute to the characteristics of the population (reviewed in [7]). This enables mutations to
exist that, by themselves, may not increase the fitness of the virus and could even be detrimen‐
tal. A combination of these mutations, that together increase the fitness of the virus, may result
in a virus with some selective advantage. Such a combination could occur by gene reassort‐
ment. The separation of different mutations on different virus segments facilitates this proc‐
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Figure 1. Genomes of influenza viruses. A) The ends of the negative strand influenza genomic RNA are complexed
with the three polymerase proteins and the remaining sequence is encapsidated with nucleoprotein (vRNP (-)). The
positive strand cRNP is similarly complexed. The mRNA is transcribed with a 5’ cap structure and poly-A tail (see main
text for details). Figure used with permission from Resa-Infante et al., 2011. B) Schematic of the influenza A virus ge‐
nome. The bold black lines represent the 3’ and 5’ untranslated regions. The blue and pink boxes represent the major
protein coding regions. C) Schematic of the influenza B virus genome. The green and brown boxes represent the ma‐
jor protein coding regions. D) Schematic of the influenza C virus genome. The red and purple boxes represent the ma‐
jor protein coding regions. The protein coding regions are not to scale. Coding regions in a different reading frame are
shown above or below each other, coding regions in the same frame are show as contiguous blocks.
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ess and allows reassortant viruses to be made if a cell is infected with two influenza viruses at
the same time.
Reassortment occurs in all three influenza virus genera [6;8;9]. But there is no evidence of
reassortment between the genera. This is likely due, in part, to the level divergence between
the viruses, both in the non-coding regulatory elements and in the proteins which interact with
each other. Also, there is evidence that one virus may suppress another through pathways that
are not well understood [10]. Reassortment has long been known to occur naturally in humans,
swine and birds [11-13].
Often evidence of reassortment is based on incongruence in the phylogenetic trees of each of
the segments. Although naturally occurring reassortants can be compared to previously
sequenced strains, the actual strains that a particular segment is derived from, and the steps
in reassortment, are only deduced. The different segments from the recent 2009 pandemic
H1N1 virus were phylogenetically similar to human, avian, and classical, Eurasian and triple
reassortant swine virus segments. Using all the available whole virus genome sequences
Bokhari et al. [14] used a bioinformatics approach to determine which viruses were most likely
homologous to the ancestors to the 2009 pandemic strain, and what reassortments needed to
occur. Interestingly, they found that among 92% of the possible paths there were certain
bottleneck viruses [14]. That is, these viruses contained the mutations and segment reassort‐
ments that made them most like the next virus in the reassortment path that eventually gave
rise to the 2009 pandemic strain. This suggests that there are certain sequence requirements
that need to be present before reassortment occurs.
Sequence analysis indicates that a disproportionate number of the naturally occurring
reassortants are the result of novel haemagglutinin and/or neuraminidase genes being
introduced into a previously circulating strain [15]. The introduction of the HA and NA
segments into another strain is also the goal of influenza vaccine seed virus strain construction.
2.1. Making vaccine seed virus
There are two predominant ways that an influenza virus can be engineered; one, by simulta‐
neous infection of a cell with two viruses each bearing some desired trait, or two, by reverse
genetics. Both methods are commonly used to produce influenza vaccine seed viruses. A
disadvantage of co-infection is that it may result in the production of viruses with unwanted
combinations of the gene segments. A disadvantage to the reverse genetic approach is that it
may be difficult to generate a virus if the introduced HA and NA genes cause a detrimental
gene constellation effect.
In the late 1950s and throughout the 1960s Edwin Kilbourne pioneered the development of
genetic recombination with influenza [16]. He recognised that an influenza vaccine seed virus
should have certain desirable characteristics; good growth, low virulence, thermal stability
and the proper antigenicity. At that time, development of high yield vaccine seed virus strains
was via empirical methods such as mouse-lung passage. Kilbourne developed and promoted
the use of “the deliberate mating of 2 or more viruses, each bearing a desired trait” so that “an
appropriate progeny virus can be selected without the need for tedious“ adaptation ”until
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appropriate mutants, if any, become manifest” [16]. This was achieved by infecting an egg with
a combination of a non-infective strain (with a high yield characteristic) and infective influenza
strain (with the desired antigenic trait) in the presence of antiserum to suppress the antigenic
proteins of the non-infective strain. This allowed for the selection of virus with the same
antigenicity as the infectious strain and the same growth characteristics of the non-infectious
strain [17]. This method for making vaccine seed virus strains has been widely used since. One
drawback of this approach is that, because the antiserum only suppresses virus expressing the
non-infective strain surface proteins, segments from the infective strain, in addition to the HA
and NA segments, are often present in the resulting strains [18;19]. This may result in an
undesirable trait being present in the vaccine seed virus strain and, as reassortments involving
whole gene segments cannot revert like single point mutations, the traits are not as easily
reverted as point mutations.
More recently, with the development of reverse genetics, it has been possible to make reas‐
sortant viruses from cloned viral segments. This allows genetically defined vaccine seed virus
strains to be produced and the methodology has been employed extensively for the production
of live attenuated vaccine seed virus strains [20]. The cold adaption and attenuation mutations
are spread out on multiple segments. A large number of human influenza vaccine seed virus
strains have been made with the cold adapted strains A/Ann Arbor/6/60-H2N2 and B/Ann
Arbor/1/66 strains [20]. High yield attenuated backbone strains for vaccination of livestock
such as birds or pigs have also been developed and are typically made using reverse genetics
[21-23]. In addition, viruses expressing the haemagglutinin from highly pathogenic avian
strains (H5N1) need to have the polybasic cleavage site removed by mutagenesis and reverse
genetic viruses made to reduce pathogenicity. Viruses made by reverse genetics use the same
plasmid derived internal gene segments. In constrast, vaccine seed strains made using in ovo
reassortment are sometimes made with a recent high growth reassortant as the non-infective
strain. This could result in the carrying forth of internal segments that are not from the high
yield strain Puerto Rico/8/1934 (PR/8) or mutations that have appeared during the passage of
the earlier reassortant strain. Although the reverse genetically engineered viruses are geneti‐
cally defined, there is no avenue for reassortment to occur if there is some incompatibility
between the glycoproteins from the season strain and the remaining proteins from the
backbone virus.
Influenza viruses are frequently isolated and propagated in tissue culture. Madin-Darby
canine kidney (MDCK) cells are widely used because they are quite susceptible to influenza
virus infection. This is because the antiviral activity of MDCK cells is lacking due to inadequate
interferon-induced myxovirus resistance protein 1 (Mx1) activity [24]. As noted above, the
introduction of HA or NA segments into circulating strains is dominant among naturally
occurring reassortants [15]. In contrast, recombinants generated in MDCK cells with no
selection show a positive correlation between other segments: most of the segment pairs that
segregate with each other in MDCK cells were polymerase combinations [25-27]. This suggests
that for naturally occurring reassortants there is some selective pressure that is not present in
laboratory-based experiments. One explanation for this bias may be due to the limited MDCK
cell antiviral response; without this response the replication efficiency of the virus might be
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the main limiting factor. Thus, viruses with combinations of polymerase factors that are most
efficient will become dominant. One report of recombinants generated in eggs without
selection described a preference for cosegregation of the HA and M segments [28]. Although
the number of reports regarding reassortment without selection is limited, the current data
suggests that egg-based experiments may more closely reflect naturally occurring events.
The replicase proteins may play a role in reassortment via their independent interaction with
each RNA segment. Each genomic segment has it’s own replicase proteins associated with it
when it enters the nucleus. A doubly infected cell is capable of producing each of the segments
from both viruses independently of each other. The timing of the overall replication will
depend on many factors such as which segments are imported into the nucleus first, translation
promoter sequences and replication signals on each segment, and the induced host response.
If a cell is simultaneously infected with two viruses, it is possible that early in the infection the
polymerase that transcribes RNA more efficiently will control the dynamics of the infection.
The resulting dynamics between the host cell and the viruses may favor the production of
either virus or a reassortant. It is unknown if the dynamics of transcription and replication
play a role in reassortment but, given that the transciption and replication signals on each
segment can differ, it is easy to imagine the dynamics of an infection being altered when a cell
is infected with two viruses. One could also imagine polymerase proteins from one strain
transcribing or replicating another strain’s RNA, or a polymerase protein from one virus
interacting with, and altering the activity of, a polymerase protein from the other virus.
2.2. Glycoproteins
There are two major surface glycoproteins for the influenza A and B viruses. The haemagglu‐
tinin (HA) protein is a sugar-binding protein that facilitates virus entry into epithelial cells that
have sialic acid sugars on the cell surface. After the HA is cleaved by a protease, the virion is
imported into the cell by endocytosis. Virus replication culminates with the accumulation of
new virions at the cell surface. The neuraminidase (NA) cleaves the glycosidic linkages of the
sialic acids to mediate virion release. The HA protein is encoded by segment 4 and the NA
protein by segment 6 in influenza A and B viruses. Influenza C has only seven segments. The
haemagglutinin-esterase-fusion (HEF) glycoprotein is encoded on segment 4 and this protein
performs the functions analogous to HA and NA of influenza A and B viruses.
In contrast to the influenza B and C viruses which are only sorted by type and strain, the
influenza A viruses are sorted into subtypes. The HA and NA proteins are used for virus
classification. There are at least 16 different HA subtypes and 9 different NA subtypes among
the influenza A viruses. The HA subtypes are divided into two groups. Certain subtypes from
both groups are able to infect and transmit among humans. Most human influenza A infections
are from H1N1, H2N2, and H3N2 subtypes. Occasionally a strain will jump the species barrier.
A limited number of avian subtypes (H5, H7 and H9) have infected humans. Sometimes the
disease is much more severe than that from a human influenza strain but these strains seem
to lack the ability to transmit from human to human efficiently. There is a fear that these highly
virulent viruses may reassort with human viruses creating virulent viruses that spread easily
among humans. New pandemic strains arising by reassortment is clearly a concern. An
Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications218
additional subtype was recently identified in bats [29]. The HA from the bat virus is more
similar to the Group 1 HAs (subtypes H1, 2, 6, 8, 9, 11, 12, 13 and 16) than the Group 2 subtypes
but the NA shows no similarity to any previously identified NA subtypes [29]. It remains to
be seen if these viruses can reassort and cause disease in humans.
Infection of humans with viruses containing swine origin HA and NA is known to occur. Like
other zoonoses, most of these swine viruses do not spread efficiently in humans. However, the
swine origin 2009 pandemic H1N1 virus spread around the world supplanting the prior
seasonal human H1N1 strains. This virus was a reassortant derived from a North American
triple reassortant H1N2 swine strain and a Euroasiatic H1N1 swine strain.
2.3. Replicase proteins
Four proteins are required for influenza virus replication; the nucleocapsid protein (NP) and
the three polymerase proteins PB1, PB2 and PA. The polymerase proteins are the larger
influenza proteins and are encoded in the largest segments 1-3. NP is encoded in segment 5.
The RNA from each viral segment form ribbon-like closed superhelical structures (reviewed
in [30]). The 5’ and 3’ ends of the RNA are in close proximity to one another and are associated
with the three polymerase proteins. Nucleoprotein is associated with the remaining genomic
RNA and there is one NP monomer present for each 24 nucleotides. Nuclear localization
sequences on NP facilitate import of each ribonucleoprotein complex (RNP) into the nucleus
(reviewed in [31]). Inside the nucleus mRNA transcription and viral replication take place.
Two of the polymerase proteins, PB1 and PB2, have biochemical interactions with NP proteins.
In addition, the three polymerase proteins interact with each other. The carboxyl-terminus of
PA interacts with the amino-terminal end of PB1 and the carboxyl-terminal end of PB1 interacts
with the amino-terminal end of PB2. The same arrangement is described for both the negative
strand viral RNA (vRNP) and the positive strand copy RNA (cRNP) with the polymerase being
associated with the 5’ end of the RNAs. New negative-strand viral genomes are derived from
the cRNP and also have a newly synthesized polymerase complex associated with the 5’ end.
The NP and three polymerase proteins all have nuclear localization signals which enable them
to be imported into the nucleus after they are synthesized in the cytoplasm. There is evidence
that PA and PB1 associate with each other before localizing to the nucleus (reviewed in [31]).
Both types of positive-strand RNA, cRNP and mRNA, are generated from the vRNP. In
constrast to the vRNP and cRNP, the mRNA is not associated with NP. The viral mRNAs also
have a capped 5’ leader sequence snatched from a cellular mRNA and a polyadenylated 3’
end. It is not yet known exactly what regulates the polymerase complex so that it makes two
distinct products from one template. The cap-binding domain is in PB2 and the endonuclease
domain is in PA. Together these parts of the polymerase complex capture and remove the 5’
capped region of cellular mRNA and this is used as the priming sequence for viral mRNA
production. The RNA-dependent RNA polymerase domain required for all RNA production
is in the PB1 protein.
Combining the polymerase proteins from different strains to produce chimeric polymerase
complexes  has  been studied with regard to  polymerase  activity  and pathogenicity.  It  is
Gene Constellation of Influenza Vaccine Seed Viruses
http://dx.doi.org/10.5772/55289
219
sometimes found, but not always, that increased polymerase activity leads to more virus and
increased pathogenicity [32]. Most recent studies have focused on the replicase genes from the
2009 pandemic H1N1 strain and prior seasonal strains. It was found that the pandemic PB2 gene
combined with seasonal PB1, PA and NP genes resulted in significantly less polymerase activity
[33;34]. Conversely, inclusion of a seasonal PB2 gene in a pandemic background significantly
increased polymerase activity.  When the corresponding reassortant  viruses,  with a  PR/8
backbone, were generated the growth kinetics for both types were reduced. This suggests that
the level of polymerase activity needs to be optimized for the best virus production in vitro. In
addition these viruses had higher mouse LD50  values suggesting polymerase activity and
replication are important for virulence [33]. Interestingly, introduction of the pandemic NP gene
into  a  seasonal  virus  also  dramatically  reduced  the  virus  replication  and  pathogenicity
demonstrating that both altered polymerase and RNP could give rise to detrimental gene
constellation effects.
In an analysis of ressortant viruses with a 2009 pandemic strain background it was found that
introduction of a PA, PB1 or PB2 segment from another virus typically reduced the virus titer
[27;35]. This included instances when all three segments from another virus increased
polymerase activity (A/swine/Korea/JNS06/04 or A/mallard/Korea/6L/07) or reduced poly‐
merase activity (A/duck/Korea/LPM91/06 or A/aquatic bird/Korea/ma81/07). Again, this
suggests that the level of polymerase activity needs to be optimized for efficient virus pro‐
duction in vitro. Each of these viruses were less pathogenic in mice but several other viruses
were generated that were more pathogenic in mice. One, containing the just the PA segment
from A/aquatic bird/Korea/ma81/07 in the 2009 pandemic backbone had a similar level of
polymerase activity to the reassortant virus containing all three A/aquatic bird/Korea/ma81/07
polymerase genes indicating that polymerase activity per se is not the cause of pathogenicity
[35]. It is possible that specific virulence determinants are associated with the PA segment but,
in the absence of a gene constellation effect, this would not account for the lower pathogenicity
of the virus containing all three polymerase segments.
One PB2 virulence marker, the amino acid at position 627, is a determinant of host range and
contributes to pathogenicity in mice [36]. It has been shown that introduction of a PB2 gene from
a low pathogenic H1N1 virus into the highly pathogenic 1918 strain attenuated the virus in mice
but pathogenicity was restored with a E627K mutation [37]. In contrast, studies of swine
influenza in pigs have shown that there is no correlation between pathogenicity and viruses
with either a swine- or avian-origin PB2 gene containing the 627K or 627E mutation [38]. While
it has been suggested that the 627 residue mediates an interaction with NP [39], and the strength
of this interaction correlates with polymerase activity [40],  recent evidence suggests that
restricted activity is due to a lack of compatibility with a host cell factor [41]. Thus, although
amino acid signatures of virulence may be important in the context of genetic drift, these results
demonstrate that gene constellation effects can attenuate virulence in some hosts.
Clearly, although specific functions of replicase complex reside in each protein, the interaction
of the replicase proteins plays a large role in several virus attributes including replication and
virulence. At present there is a lot of genetic information for the replicase genes available.
Unfortunately our current understanding of influenza replication does not enable the predic‐
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tion of replication efficiency or associated pathogenicity based on replicase gene sequence
alone. While new functional information is being generated regularly, a more complete
understanding of influenza replication and its contribution toward pathogenicity will require
more comprehensive structure-function information.
2.4. Other proteins
There are at least four additional proteins produced during influenza infection of a cell. The
two segments not mentioned so far, segments 7 and 8, are the smallest genome segments. In
both influenza A and B viruses each of these segments encodes at least two proteins. The
analogous segments in influenza C viruses are segments 6 and 7 (Figure 1).
Influenza A segment 7 encodes two matrix proteins; M1 and M2. The M2 proteins from
influenza B and C viruses are called BM2 and CM2 respectively. M1 binding to RNPs in the
nucleus inhibits viral transcription [42;43]. M1 proteins form a continuous shell on the inner
side of the lipid bilayer. M2, and the analogous BM2 and CM2 proteins, are ion-channel
proteins that form as a homotetramers in the virus envelope. These small hydrophobic integral
membrane proteins allow hydrogen ions to enter the viral particle from the endosome. The
lower pH causes M1 to dissociate from the RNPs leading to the uncoating of the virus. Different
coding strategies are used by the different influenza species (Figure 2 and [44]). M2 protein is
translated from a spliced transcript while BM2 protein is translated by a coupled termination/
reinitiation event [45;46]. In contrast CM1 is translated from a spliced transcript and CM2 is
the produced by peptidase cleavage of a precursor protein [47;48]. Influenza B viruses encode
an additional small hydrophobic integral membrane protein on segment 6. The open reading
frame starts 4 nucleotides upstream from the NA ORF (Figure 2). Although NB is conserved
in influenza B genomes it is apparently not essential and it’s function remains unknown at
present [49]. Interestingly, influenza A viruses also encode an alternative M2 protein on a
splicing variant [3]. The same conserved redundancy in two different influenza families
highlights the importance of the ion channels for the viruses. This diversity in coding and
expression of similar functions may also be a reason why reassortant viruses containing
segments from different influenza types are not readily obtained.
The smallest influenza segment encodes the non-structural protein NS1 and the nuclear export
protein xlink. xlink is translated from a spliced transcript and is incorporated into the virions
in small numbers (Figure 2). The major role of NS1 is to modulate the host immune response.
It is a multifunctional protein that interacts with several host proteins and has an RNA binding
domain (reviewed in [50]). Protein sequence features from influenza NS1 proteins indicate that
there are variant types that seem to correlate with certain host species [51]. The exact nature
of this relationship has not been teased out yet. The NS1 protein from the 2009 pandemic strain
was less effective at blocking the innate immune response in cultured cells than other seasonal
strains but attempts to make the 2009 NS1 protein more like the seasonal strain did not result
in the same effect, rather the virus had reduced the virulence and was more easily cleared [52].
A better understanding the relationship between NS1 from specific virus strains and the host
cell type could lead to the development of vaccine seed virus backbone strains that are more
suitable for vaccine production.
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The presence of segment 7 or 8 from differing viruses can alter the phenotype of another virus.
For example, addition of different NS segments from an H3N2 virus or different H5N1 viruses
into a PR/8 backbone could result in no attenuation or complete attenuation [53;54]. Similarly,
the same gene can have different effects on different viruses. For example, replacement of the
A/Korea/82 (H3/N2) M segment with the A/Ann Arbor/6/60 M segment attenuated the virus.
However, introducing the same A/Ann Arbor/6/60 M segment into A/Udorn/72 (H3/N2) did
not attenuate the virus [55]. This clearly demonstrates the greater impact the gene constellation
has toward the virus phenotype than an individual segment in this instance.
The characterization of the laboratory generated reassortants provides useful hypothesis-
driven information. Natural reassortment of the smallest influenza segments may give
additional information about the role these segments play in the virus lifecycle. Some viruses
isolated recently from North American pigs contain the 2009 H1N1 M segment in the context
of a previously endemic H1N2 strain [56]. This suggests that this particular gene constellation
may increase viral fitness. Supporting this Chou et al., [57] were able to show that inclusion of
the M segment in a PR/8 backbone was essential for transmission in guinea pigs. Another group
reported that the neuraminidase segment from the 2009 H1N1 strain, in addition to the M
segment, was required for efficient replication and transmission in pigs [58]. Finally, Hause et
al. [59] reported transmission but lower viral titers for the reassortant viruses containing the
M segment from the 2009 pandemic strain in pig lung homogenate when compared to infection
with the parental strains. The major difference between the viruses analyzed by these groups
is that the backbone strains differed; one group used comtemporary H1N2 swine viruses to
generate reassortants while the other groups used laboratory adapted strains. The different
outcomes observed are based on gene constellation effects.
3. The gene constellation effect
It stands to reason that if a certain gene constellation confers some desirable attribute then
viruses containing those segments should occur more often in the population over time than
other reassortments. That is, the combination of gene segments should occur independently
many times in a large enough population if the same parental viruses continue to co-circulate
in the population. However, if the reassortant has a relative fitness that is much greater than
other circulating strains then the virus may quickly replace other virus strains in the popula‐
tion. An example of this is the emergence and spread of the 2009 pandemic H1N1 strain. Very
quickly, and during a season not typically associated with high influenza rates, the 2009
pandemic strain became the prevalent H1N1 strain and prior seasonal H1N1 strains become
less common [60].
Possibly more common, but less well documented, are reassortants that have a small increase
in fitness compared to the parental strains. A recent analysis of reassortant H3N2 viruses in
swine demonstrated that multiple reassortants generating the same gene constellation
occurred [61]. Several H3N2 swine lineage viruses were isolated from humans in 2011 and
found to contain the segment 7 from the 2009 pandemic H1N1 virus. This prompted Nelson
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and colleagues to analyze the reassortants present in swine populations. What they discovered
was that, in addition to the reassortants that transmitted to humans, reassortants in swine with
a range of genetic backbones contained the 2009 pandemic segment 7 [61]. It is not known if
the presence of the 2009 segment 7 in swine viruses plays a role in viral fitness in swine or if
it has a role in zoonotic infection of humans, but clearly the presence of this segment gives rise
to viruses from different reassortment events that are stably represented in the population.
In addition to the appearance of this particular gene constellation in North America pigs, gene
constellations involving all segments from the 2009 pandemic strain are becoming dominant
in other parts of the world. It has been reported that the 2009 pandemic strain is present in
pigs and reassorting with H1N2 and H3N2 strains [62-65]. It is not clear how the combination
of gene segments present in strains like the 2009 pandemic strain results in a greater viral fitness
but study of different viral characteristics has given us some insight. Here we highlight
research describing the effect different gene constellations have on viral fitness.
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Figure 2. Coding strategies of influenza viruses (adapted from Lamb & Takeda, 2001). A) Multiple splice variants are
transcribed from one segment to enable the production of multiple proteins. As many as four mRNAs (and proteins)
are produced from influenza A segment 7. The mRNA from the smallest segment of all influenza species is spliced for
the translation of the nuclear export protein xlink. B) A larger protein is translated and processed to produce the influ‐
enza C protein CM2. The M1 protein is produced from a spliced mRNA. C) Different AUG start codons are used to pro‐
duce up to three proteins from influenza A segment 1. A second membrane protein, NB, is produced from an
alternative start codon in segment 6 of influenza B. D) The termination and start codons of the respective M1 and
BM2 open reading frames in segment 7 of influenza B overlap. A stop/start translation strategy is used to produce the
second protein.
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3.1. Altered pathogenicity
There have been many efforts to understand which gene segments contribute to pathogenicity.
If a particular segment were known to contribute to pathogenicity in a vaccine strain then
safeguards could be put in place to prevent the generation of the gene constellations containing
the offending segment(s). The current recommendation for Institutional Biosafety Committees
in the United States is that gene constellation be included in the evaluation for determining
the biocontainment level for influenza work [66]. One difficulty in applying this recommen‐
dation is that the pathogenicity of a virus in one host species may differ greatly from the
pathogenicity in another host species. Another difficulty is that new strains emerge and evolve
faster than the pathogenicity of the gene combinations can be assessed. Here we reflect on what
is known about gene constellation and pathogenicity.
In the 1970s it became clear that both the glycoproteins and the internal proteins play a role in
pathogenicity. In many experiments segments from a human or animal origin virus were
introduced into a pathogenic avian influenza virus and pathogenicity tested in chickens. Often
the pathogenicity was reduced [67;68]. However, increased monitoring of avian influenza
viruses in Hong Kong indicated that most naturally occurring reassortant H5N1 viruses were
lethal to birds [69]. Serial passage of pathogenic avian influenza in MDCK cells and selection
of large plaques resulted in reduced pathogenicity in mice suggesting that differences in the
host cell type that the virus is propagated in play a role in pathogenicity [70]. Interestingly, the
attenuated variants all had common mutations in the polymerase genes and grew to higher
titers on MDCK cells than virus purified from small plaques. This suggests that an equilibrium
between replication efficiency and pathogenicity is being altered when a virus is adapting to
a new host. This is in contrast to the increased pathogenicity seen when faster growing viruses
are compared to slower growing viruses in the same host; for example, avian viruses grown
in eggs [71;72].
There are other examples of changes in the replication machinery of the influenza virus
affecting pathogenicity. In one study it was found that reassortant avian H5N1 viruses
containing the PB2 gene from a human H3N2 virus had increased pathogenicity in mice [73].
It was also shown that the introduction of a human PB1 segment alone did not enhance
pathogenicity but had a cooperative effect when the human PB2 was present. As noted above,
the segments containing the polymerase often cosegregate, which could be troubling if this
enhances pathogenicity.
Pathogenicity is not only dependent on the virus, it also depends on the host species and even
where in the host the virus replicates [74]. The pathogenicity caused by a virus is often due to
the host response to the virus and is perhaps best exemplified by the cytokine storm. In such
instances an excessive amount of proinflammatory cytokines are released and inflammation
spreads from the site of infection. Acute lung injury, or the more severe acute respiratory
distress syndrome, is associated with influenza infections (reviewed in [75]). As the NS-1
protein encoded on segment 8 has a role in modulating the host immune response, one would
expect that segregation of segment 8 during reassortment might alter virus pathogenicity.
However, while addition of an H3N2 NS segment to a 2009 H1N1 virus increased replication
efficiency, the virus was not as pathogenic in mice as the parental H1N1 strain [54]. Also, the
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addition of an H5N1-derived NS segment to a PR/8 backbone attenuated the virus when tested
in mice [53]. Because PR/8 is a high growth strain these results may not be truly representative
of the effect the NS gene can have. When the NS segment from a highly pathogenic H5N1
strain was added to a highly pathogenic H7N1 strain the virus was more pathogenic in mice
[76]. Here the observed increase in virulence was also associated with enhanced cell tropism.
This demonstrates the potential for reassortants created in a host specific manner to gain the
ability to jump the species barrier.
The 2009 H1N1 pandemic virus arose by reassortment of swine influenza viruses of different
lineages. The NA and M gene segments were from the Eurasian avian-like swine virus lineage
and the remaining segments were from the North American triple reassortant lineage. The
triple reassortant lineage emerged in the 1990s with the PB2 and PA segments derived from
an avian virus, the PB1 from a human virus and the remaining segments from the classical
swine lineage. With all three swine lineages circulating, and reassorting, there is a concerted
effort to characterize current and possible reassortants for their potential to infect humans
[62;65]. The ferret is a widely used model for assessing pathogenicity and transmission of
viruses. Unlike mice, but like humans, ferrets infected with a seasonal influenza strain present
with an increase in temperature, nasal secretions, sneezing and sometimes with a cough,
making them suitable for study of human viruses. Triple reassortant swine viruses isolated
before 2009 did not produce clinical signs of respiratory symptoms like sneezing and nasal
secretions [77]. The pathogenicity of these viruses was similar to the 2009 pandemic virus with
more lung pathology than seasonal viruses [77]. All the triple reassortant viruses transmitted
between ferrets by direct contact but only those with human-like HA and NA were transmitted
efficiently by respiratory droplets [65;78]. Addition of a seasonal H3N2 NA to a 2009 pandemic
virus gave rise to more severe pulmonary lesions in ferrets demonstrating the importance of
gene constellation [79]. Further, it has been shown that the tropism of such a virus is linked to
the balance between HA and the NA even when the replication competence is lower [62]. For
influenza vaccine seed viruses it has been hypothesized that a lower NA content in the virion
can increase HA content [80].
3.2. Altered growth rates
A high growth phenotype in a virus seed strain is beneficial for vaccine production. There are
many proteins that might have an effect on the virus growth rate. The envelope proteins
determine the infectivity through effects on attachment, entry and budding. The replicase
proteins affect the speed of transcription and replication. And finally, NS1 protein modulates
the host response. Thus, differing combinations can result in changes in growth rates. Many
vaccine seed strains have been made using PR/8 as the backbone, that is, replacement of the
HA and NA segments whilst retaining the six remaining PR/8 segments. Usually the intro‐
duced HA and NA segments come from the same virus so one would assume that the encoded
proteins are compatible with each other. Thus, any reduction in growth rate is due to the
change in interactions between the HA and NA combination and other proteins. Increased
growth rates are often achieved by passaging the virus but the enhanced growth sometimes
results in antigenic changes to HA rather than adaptation of the other proteins.
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Many insights about virus growth have come from analysis of changes on one segment. It has
been observed that culture of many influenza viruses in eggs results in amino acid changes in
HA as the virus adapts to the new host. Similar observations have been made when viruses
are grown in different cell types. For example, most viruses have an asparagine residue in the
haemagglutinin at position 117 (H1 subtype) or 116 (H3 subtype). Substitution of this residue
with aspartic acid does not alter the growth in MDCK cells but enhances growth in Vero cells
[81]. This mutation was shown to alter the pH range for virus membrane fusion indicating that
this is an important factor for optimal growth [81]. However, HA does not act in isolation and
the best growth of vaccine seed strains will depend on how differences in HA affect interactions
with other proteins, in particular, the other major envelope proteins NA and M.
The introduction of HA from a seasonal H1N1 virus into the 2009 pandemic strain backbone
resulted in larger plaque size and higher viral titers in cell culture [82]. It was further shown
that, in contrast to the predominantly filamentous parental strains, the reassortant virus was
predominantly spherical and enhanced yields could be obtained by introducing the same
seasonal HA into other swine-origin backbones [82]. By using the opposite approach, introduc‐
ing swine-origin segments into the seasonal virus backbone Octaviani et al. were able to show
that the high yield was primarily due to the presence of swine-origin HA and M segments [82].
The HA and NA segments from A/Vietnam/1194/2004 and the PR/8 backbone were combined
to make a reassortant prepandemic vaccine seed virus but it gave low antigen yield and did
not grow well. Incorporation of the M gene segment from the A/Panama/2007/1999 H3N2
strain or from the A/Vietnam/1203/2004 H5N1 strain enhanced growth [83]. The M1 proteins
differed at positions T167A, R174K, I219V, A227T and A239K, while the M2 proteins differed
at positions N31S, R54L, Y57H, S82N and G89S from the PR/8 segment 7 proteins. It is unknown
how the synergy between these segments works but, with structures available for the major
envelope proteins and advances in electron tomography, these interactions may be revealed
in the near future [84].
Several vaccine seed strains have included the seasonal PB1 gene [18;19]. Growth rates were
also shown to improve when the indigenous PB1 was included in the 2009 H1N1 reassortant
[85] and with a H5 reassortant [86]. However, this result did not extend to a different H5
reassortant [83]. We postulated that certain residues within the PB1 protein might be important
for growth and yield. Rather than target those amino acids known to be involved enzyme
activity or protein interactions with the other polymerase proteins, we made changes based
on sequence similarity between diverse PB1 proteins that reassorted in ovo during the pro‐
duction of influenza vaccine seed viruses. Using this impartial approach, we made changes to
the PR/8 PB1 gene that, when combined with the HA and NA from the low yield H3N2
Wyoming/03 strain, resulted in faster growth in both egg and cell culture [87].
3.3. Altered protein production
The 5’ untranslated regions of the influenza A genomic segments contain signals that stimulate
translation. These signals regulate the amount of protein produced from each segment and
differ between segments. The non-coding regions also differ in length among the different
segments and virus types [88-90]. The sequence motifs AGGGU and GGUAGAUA that are
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recognized respectively by the host protein G-rich RNA sequence binding factor 1 (GRSF-1)
and the viral NS1 protein may also be present in the non-coding regions (reviewed in [1]). Both
of these proteins have been shown to stimulate translation [91;92]. In addition, there are
changes in translation that most likely due to changes in the RNA structure. Single nucleotide
changes in the 5’ and 3’ non-coding regions of PA were shown to have no effect on translation
individually, but together these changes almost completely abolished protein expression [90].
It is not known if the changes altered mRNA production or affected translation itself, but one
would expect that the resultant loss of viral protein would affect virus replication and possibly
virulence. Indeed, the mutations that resulted in low protein production were based on the
sequence of a low pathogenic avian influenza virus.
Very  similar  viruses  may  produce  quite  different  amounts  of  viral  protein  and  several
groups have tried to find the underlying reasons. It is common for several reassortants to
be made using different seasonal isolates in an effort to create a suitable high yield vaccine
seed virus. As noted previously the PB1 segment from the seasonal strain was found in
many  high  yield  reassortants  made  for  vaccine  manufacture  [18].  Analysis  of  protein
production from reassortants with or without the seasonal PB1 segment and the 2009 H1N1
HA and NA as been performed. One group found that the presence of the PB1 from the
2009  strain  increased  protein  yield  while  another  found  that  it  decreased  protein  yield
[85;93]. Both groups used PR/8 as the high yield donor strain but they each used differ‐
ent 2009 pandemic isolates. This highlights one difficulty in predicting what gene constel‐
lations may be beneficial for protein production; minor strain variations may have major
translational effects. Comparison of both the PR/8 strains and both 2009 pandemic strains
used in these studies may provide interesting information.
3.4. Incomplete genomes and RNA structure
The in vitro production of ressortant viruses using the classical reassortant method involves
high multiplicities of infection to increase the chance of both viruses infecting cell.  Early
studies  demonstrated  that  passage  of  influenza  at  high  multiplicities  of  infection  could
result in the production of non-infectious particles [94;95]. These particles are now known
as defective interfering, or DI, particles. Subsequently it was discovered that the polymer‐
ase genes frequently contained deletions [96;97].  Thus, although eight genomic segments
were packaged, the viruses could not make proteins essential for replication. In addition,
non-infectious  particles  lacking  the  glycoproteins  have  also  been  described  [98].  This
explains the loss of infectivity even though many particles are detected by haemagglutina‐
tion [99]. Kaverin et al., [99] were able to show that one fraction of a DI population could
complement  another  fraction  of  the  DI  population.  More  recently,  Odagiri  and  Tashiro
[100] were able to show that non-coding sequences were responsible for the preferential
packaging of DI RNA rather than the full  length RNA segment.  It  is  not clear when or
how the portions of the RNA are deleted but it is likely that the structure and the sequence
of  the  RNA play  a  significant  role.  Using a  bioinformatics  approach,  Priore  et  al.  [101]
analyzed the extensive base pairing that exists throughout the genomic segments of avian,
swine and human influenza A viruses.  The results  indicated that  there  were significant
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differences  between  species  in  the  PB2,  NP,  M  and  NS-containing  segments.  These
differences were only on the positive strand which could indicate a role in either protein
production  or  negative  strand  synthesis.  Given  that  these  segments  do  not  reassort  as
frequently as the other polymerase segments or glycoprotein segments, it would seem that
genome  wide  RNA  structural  organization  does  not  contribute  to  reassortment.  Al‐
though, it  is  postulated that global organizational RNA structure could be a mechanism
by which the virus adapts to the host environment [101] leaving open the possibility that
the  RNA  structure  of  a  particular  segment  affects  the  chances  of  it  being  involved  in
reassortment.
DI particles represent an evolutionary dead end with regard to a natural infection. However,
particles that lack a complete genome could be either detrimental or beneficial in vaccine
production. Particles that are defective in the polymerase will alter growth characteristics and
would not function in a live attenuated vaccine. In contrast, particles with incomplete genomes
represent an abundance of antigen with no pathogenicity, which could be viewed as desirable
in an inactivated vaccine.
4. Conclusion
Understanding the gene constellation effect in influenza is important, especially for vaccine
production. The mixing and matching of influenza genomic segments in nature and in the
laboratory gives rise to new viruses with phenotypes that differ from the ancestral viruses. In
nature, this may be a more pathogenic virus or one that has an expanded host range. In the
laboratory, attenuated viruses with good growth characteristics and high protein yield are
desirable for study and vaccine production. A greater understanding of what contributes to
the gene constellation effect may enable researchers to produce influenza vaccine seed viruses
that facilitate production with reduced risk of infection.
As we have described in this chapter, current research has provided some insight into the
genomic features that contribute to the gene constellation effect, but more work needs to
be done.  Some segments,  such as  those encoding the glycoproteins  and the polymerase
proteins, appear to be more frequently involved in reassortments. The reassortment of the
polymerase  proteins  is  more  common in  laboratory  manipulation  whereas  the  reassort‐
ment  of  glycoproteins  is  more  common in  nature.  The  beneficial  effects  of  certain  pro‐
tein:protein  interactions  may  be  the  underlying  impetus  behind  some  of  these
reassortments. For example, certain combinations of HA, NA and M can lead to changes
in transmission and growth. Likewise, certain combinations of PB1, PB2 and PA can affect
polymerase  activity  and  growth.  Also,  the  two  smallest  segments  have  effects  on  cell
tropism and viral fitness. The amount of polymerase activity is not directly associated with
virus titer suggesting other factors affecting replication must be balanced with replication
efficiency.  Changes in  the  polymerase  segments  can also affect  pathogenicity,  especially
when the virus is adapting to a new host cell. Changes in the glycoproteins have also been
shoen to affect pathogenicity.  While much work has focused on either the glycoproteins
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or  the  replicase  proteins  independently,  some of  the  work described here  demonstrates
that these two groups of proteins have an effect on each other.  The interaction between
these two groups of proteins at a functional level needs to be elucidated.
While several groups have analyzed the genomes of reassortant viruses there is still a great
need  for  better  understanding  what  features  contribute  to  genomic  reassortment.  With
more whole virus genome sequences available for analysis there is a better chance that the
features important for reassortment can be determined. Retrospective analysis of reassor‐
tant viruses can illuminate which genomic features are compatible. In vitro construction of
reassortant viruses can highlight which segments, or parts of segments, are not compati‐
ble. After a reassortment event is detected there needs to be more analyses of the muta‐
tions that occurred in each segment as they may have facilitated the reassortment event.
Mutations necessary for reassortment would occur prior to reassortment and perhaps be
present in bottleneck viruses. Mutations that occur with passage are those that increase the
fitness  of  the  reassortant.  Description  of  both  types  of  mutations  would  enhance  our
understanding of  the  network of  interactions  between viral  proteins.  In  addition to  the
changes in coding sequences, analysis of the untranslated regions of the genomes is also
important. There is no available information about the compatibility of segments with the
replication and translation machinery, or how this contributes to the gene constellation.
Finally, an understanding of the gene constellation effect will allow for the selection of better
reassortant viruses for vaccine production. Currently both the in ovo and reverse genetic
methods use an impirical approach to get the best viruses that express the desired HA and NA
proteins. Knowing how the different segments contribute to the network of interactions that
result in high yield will enable researchers to produce strains that will provide the best
backbone for an influenza vaccine seed virus. The optimal backbones may be universal, or
differ for the different virus subtypes, or differ according to the host species that the virus
providing the HA and NA infects. But without optimal virus backbones, the production of
high yield reassortant influenza vaccine seed viruses will remain inefficient.
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